For rural hospital and health system leaders: which prenatal services a hospital can keep after a labor and delivery unit closes, and how home ultrasound supports fetal checks between visits.

TL;DR
- At least 96 labor and delivery units closed across 35 states from January 2024 to May 2026, and in nearly 60 percent of affected counties the closed unit was the only local birthing facility.
- A hospital can keep routine prenatal and postpartum visits local through telehealth with a hub obstetric team, while delivery moves to a partner hospital.
- Home monitoring covers the gap between visits: blood pressure and glucose tracking, and clinician-reviewed home ultrasound for fetal heart rate.
- Pulsenmore ES is a physician-prescribed home prenatal ultrasound system with FDA De Novo marketing authorization that adds fetal heart rate checks to a rural hospital’s remote prenatal program.
- A multicenter U.S. study, an outcomes cohort of 4,460 users, and studies of patient experience and hybrid care support the approach.
A rural hospital can offer prenatal care after its labor and delivery unit closes by keeping routine prenatal and postpartum visits in its own clinic, linking those visits by telehealth to an obstetric hub, and adding home monitoring for the checks that happen between visits. Delivery moves to a partner hospital through a defined transfer agreement. The local clinic stays the entry point for pregnant patients, so they travel for delivery and specialist care and not for every routine visit.
What a delivery unit closure removes, and what a hospital can keep
The Center for Healthcare Quality and Payment Reform counted 116 rural labor and delivery closures since the end of 2020, with 950 rural hospitals still offering the service. March of Dimes’ 2026 report found that recent closures added an average of 25 minutes of travel in affected communities. Closure removes the delivery service, and prenatal care is a separate service the hospital can choose to keep.
In northeastern New Mexico, a HRSA-funded rural maternity program connected small hospitals to an obstetrician by video, and at the Raton hospital first-trimester prenatal no-shows fell from 41 percent to 25 percent over two years, according to 2023 reporting. The same report noted that the grant-funded pilots were ending and that the clinician wanted to keep home monitoring devices for patients, so funding after a pilot needs planning.
Models hospitals use
ASTHO describes three strategies: birth centers, hub-and-spoke coordination, and telehealth. South Dakota’s Maternal Health Compact links a Level III care center with two lower-level rural facilities.
Who provides each part of prenatal care after closure
| Care need after closure | Provided by | Tool |
| Routine prenatal and postpartum visits | Local clinic, linked to the hub obstetric team | Video visit, local nurse for vitals |
| Blood pressure and glucose between visits | Patient at home, reviewed remotely | Home cuff, glucose monitoring |
| Fetal heart rate between visits | Patient at home, reviewed by the care team | Clinician-reviewed home ultrasound |
| Diagnostic ultrasound and specialist input | Hub partner hospital | In-person ultrasound, maternal-fetal medicine |
| Delivery and emergencies | Delivering hospital, through a transfer agreement | Hub-and-spoke link |
How home ultrasound fits between visits
Pulsenmore ES gives the local prenatal clinic a way to check fetal heart rate between visits without a trip to the hub. The patient docks a handheld transducer to her smartphone and follows the app through a scan that takes about three minutes. In app-guided mode the patient scans independently and submits the scan for review, and in clinician-guided mode a clinician guides the scan in real time. The platform supports role-based workflows: an administrator schedules appointments, a sonographer or midwife reviews scans and records findings, and a doctor gives the final sign-off, which frees doctors for patients who need to be seen face to face.
A physician prescribes the device, which is authorized for singleton pregnancies between 14 and 38 weeks of gestation. Rural programs should check connectivity: app-guided scans need no live session, but internet access is still required to transmit scans, and Pulsenmore recommends home Wi-Fi, with 5G or 4G as an alternative.
For the clinical record behind this approach, read Pulsenmore’s review, Transforming obstetric care: the impact of patient-operated home ultrasound and remote diagnosis in hybrid prenatal care.
What the evidence shows
In a study of 100 women in Israel, fetal cardiac activity was detected in 95.3 percent of scans by patients scanning themselves. In the multicenter U.S. HOLA study, which supported the FDA authorization, 162 women at four institutions performed 1,370 scans, and fetal cardiac activity was assessed successfully in 99.2 percent of clinician-guided and 96.5 percent of app-guided scans. A retrospective cohort in BMC Pregnancy and Childbirth found no significant association with preterm delivery or adverse neonatal outcomes among 4,460 users and 102,707 matched non-users. A randomized trial in women with recurrent pregnancy loss reported lower anxiety and higher maternal-fetal attachment, and that result applies to that population.
Sheba Medical Center’s hospital-at-home program for high-risk pregnancy combines daily remote visits, glucose monitoring, fetal heart tracing, and Pulsenmore ultrasound, and it had 93 patients by February 2025. Pulsenmore’s partnership with Ouma Health shows the device being added to a U.S. virtual maternity care platform that serves patients in maternity deserts.
Practical Takeaways for rural hospital leaders
First, decide which prenatal and postpartum services the hospital keeps after closure, and write them down as the local scope. Second, sign a hub agreement for telehealth visits, ultrasound review, and transfer. Third, add home monitoring for each unmet need and name the roles that review each result. Fourth, check broadband and smartphone access for the patients who will use it. Fifth, plan how the program continues after any grant ends.
Teams evaluating home ultrasound for a rural prenatal program can start at Pulsenmore’s home ultrasound page and the Pulsenmore resource center.
FAQs
Q: Which patients can use Pulsenmore ES?
A: It is designed for use from week 14 of pregnancy and for single-fetus pregnancies. A physician prescription is required, and each device is personal and intended for one patient during one pregnancy.
Q: How does a rural hospital start offering Pulsenmore ES?
A: Healthcare providers and organizations interested in integrating Pulsenmore into their prenatal care programs can contact the company directly through its website. The Pulsenmore team works closely with each organization to understand its clinical needs, develop an appropriate care model, and support implementation. Once the program is established, eligible patients can access home ultrasound as part of their provider’s prenatal care services.
Q: Can patients with limited connectivity use it?
A: Pulsenmore ES supports two scanning modes with different connectivity requirements. Clinician-guided scans require a live connection with a healthcare professional, while app-guided scans can be performed independently, without a live clinical session. However, internet connectivity is still required to transmit scans for clinician review. Healthcare providers should assess connectivity and smartphone compatibility when determining patient eligibility.
Q: What evidence supports Pulsenmore ES?
A: Pulsenmore is supported by a growing body of clinical evidence, including a pivotal multicenter U.S. study involving 162 women and 1,370 scans, which supported its FDA De Novo authorization. A large real-world study in Israel compared pregnancy outcomes among 4,460 Pulsenmore users and more than 102,000 non-users, finding no significant association between home ultrasound use and adverse pregnancy outcomes. Additional published research has explored maternal anxiety, patient experience, and the integration of home ultrasound into hybrid prenatal care models, including studies in the Netherlands and Israel. Beyond clinical trials, Pulsenmore reports more than 270,000 home ultrasound scans performed in real-world settings.
Q: Is Pulsenmore ES available in the United States now?
A: Yes. Pulsenmore launched U.S. commercial operations in 2026, with initial agreements with the Center for Fetal Maternal Ultrasound in Los Angeles and TLC Perinatal Care in Maryland, followed by a partnership with Ouma Health to expand access to remote prenatal care. Healthcare providers interested in offering Pulsenmore home ultrasound can contact the company directly to learn more about the technology and integrate it into their prenatal care services. Once enrolled, eligible patients can purchase the device directly through Pulsenmore’s website with a prescription from their healthcare provider.
Q: Who reviews the scans at a small rural clinic?
A: Review can be split by role. An administrator schedules appointments, a sonographer or midwife reviews scans and records findings, and a doctor gives the final sign-off. This lets a clinic with limited physician time keep doctors available for patients who need to be seen face to face.
Q: How does reimbursement work for Pulsenmore home ultrasound in the U.S.?
A: Pulsenmore can be integrated into existing prenatal care models. Under a common commercial approach, healthcare providers offer the home ultrasound device to patients for a fee and may seek reimbursement from insurers for eligible ultrasound services performed and interpreted by clinicians. Reimbursement depends on the services provided, applicable billing codes, payer policies, and individual coverage arrangements. Pulsenmore works with healthcare organizations to explore clinical and commercial models that fit their practice.